Physician profile
Eric C Poston
NPI 1487652624
$11,273.62
in general payments reported to CMS, 2019-2025
49 companies · $2,160 in 2025
The $2,160 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,009 · 2020: $872 · 2021: $1,675 · 2022: $1,669 · 2023: $1,675 · 2024: $2,213 · 2025: $2,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,049.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,048.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,384.16 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $1,140.94 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,121.64 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $978.88 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $919.14 | 2019-2025 | Lifevest |
| Pfizer INC. | $805.93 | 2019-2025 | |
| Amgen INC. | $693.41 | 2019-2025 | Otezla, Repatha, Evenity |
| Lilly USA, LLC | $465.74 | 2020-2025 | Mounjaro, Zepbound, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $428.31 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $329.30 | 2022-2025 | |
| Lundbeck LLC | $300.92 | 2023-2025 | Vyepti, Rexulti |
| Xeris Pharmaceuticals, INC. | $248.72 | 2021-2025 | Gvoke Hypopen |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $233.41 | 2022-2025 | Caplyta |
| Radius Health, INC. | $200.68 | 2020-2023 | Tymlos |
| Novartis Pharmaceuticals Corporation | $180.44 | 2019-2024 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Poston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.